Paraumbilical Hernia

2

Review clinical trials related to Paraumbilical Hernia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Comparison of Extended Totally Extra-peritoneal Repair (ETEP) and Subcutaneous On-lay Endoscopic Approach (SCOLA) for Para-umbilical Hernia (PUH).

The goal of this clinical trial is to learn if one of two surgical techniques works better for treating paraumbilical hernias in adult men and women between 18 and 65 years old. The main questions it aims to answer are: Does one technique lead to fewer complications after surgery, such as infection or fluid buildup (seroma)? Does one technique result in less pain or a shorter operating time? Researchers will compare the ETEP repair group to the SCOLA repair group to see if one method leads to better outcomes for patients. Participants will: Be randomly assigned to receive either the ETEP or SCOLA surgical repair. Have their surgery and recovery tracked by the research team. Attend follow-up visits for up to six months to check for any complications.

Participants needed: 86
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: King Edward Medical UniversityUpdated: Feb 25, 2026Locations: 1
Eligibility criteria

Adults of the age group from 18 to 65 years [+1]

Patients with a hernial defect more than 5cm, documented in the perioperative fi... [+4]

Status: Not yet recruiting

Comparison Between External Oblique Intercostal Plane Block and the Transversus Abdominis Plane Block in Paraumbilical Hernia Repair as Analgesia for Intraoperative and Postoperative Pain.

AIM OF STUDY: Comparison between effect of external oblique intercostal plane block and the Oblique subcostal transversus abdominis plane block in paraumbilical hernia repair as analgesia for intraoperative and postoperative pain.

Participants needed: 62
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Assiut UniversityUpdated: Jun 6, 2024
Eligibility criteria

Age between 18 and 65 years with a body mass index (BMI) of 18-35 kg/m2 [+2]

1-Known hypersensitivity to the study drugs. 2-Body Mass Index > 40 kg/m2. 3- In...